US6126590A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Cardiac reinforcement device
Assignee: Resonac Corp
•
Filing: 1997-09-23
•
Granted: 2000-10-03
•
Expires: 2017-09-23
Abstract
Abstract The present disclosure is directed to a cardiac reinforcement device (CRD) and method for the treatment of cardiomyopathy. The CRD provides for reinforcement of the walls of the heart by constraining cardiac expansion, beyond a predetermined limit, during diastolic expansion of the heart. A CRD of the invention can be applied to the epicardium of the heart to locally constrain expansion of the cardiac wall or to circumferentially constrain the cardiac wall during cardiac expansion.
Inventors
- 👤 Clifton A. Alferness
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:26
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2478; A61F2/2481; A61M; A61M60/00; A61M60/10; A61M60/122; A61M60/126; A61M60/161; A61M60/20; A61M60/247; A61M60/253; A61M60/268; A61M60/40; A61M60/465; A61M60/47; A61F2002/2484; A61F2250/00; A61F2250/0003
Claims Analysis
Total Claims: 35
Claim 1
Independent Claim
152 words
A method for treating valvular a conditions of a patient's heart, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a synthetic biomedical material which can be applied to an epicardial surface of the heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (ii) said synthetic biomedical material comprising a continuous mesh construction, said continuous mesh construction defining a plurality of open cells; (iii) said synthetic biomedical material formed into a jacket to surround said heart with said jacket having an internal volume to receive said heart; (b) applying said cardiac reinforcement device to said surface of said heart under a parietal layer of a pericardium of said heart; and (c) securing said cardiac reinforcement device to said surface of said heart with said jacket adjusted for said internal volume to assume said maximum predetermined size.
Claim 2
Independent Claim
152 words
A method for treating valvular a conditions of a patient's heart, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a synthetic biomedical material which can be applied to an epicardial surface of the heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (ii) said synthetic biomedical material comprising a continuous mesh construction, said continuous mesh construction defining a plurality of open cells; (iii) said synthetic biomedical material formed into a jacket to surround said heart with said jacket having an internal volume to receive said heart; (b) applying said cardiac reinforcement device to said surface of said heart under a parietal layer of a pericardium of said heart; and (c) securing said cardiac reinforcement device to said surface of said heart with said jacket adjusted for said internal volume to assume said maximum predetermined size.
Claim 3
Dependent Claim
17 words
The method for treating valvular conditions according to claim 1 wherein said valvular condition is valvular insufficiency.
Claim 4
Dependent Claim
19 words
The method for treating valvular conditions according to claim 1 wherein said biomedical material is a substantially non-elastic material.
Claim 5
Dependent Claim
25 words
The method according to claim 1 wherein the maximum predetermined size of the cardiac reinforcement device is less than an initial diastolic cardiac expansion volume.
Claim 6
Dependent Claim
19 words
The method according to claim 1 wherein said cardiac reinforcement device circumferentially surrounds the epicardial surface of the heart.
Claim 7
Independent Claim
133 words
A method for treating cardiac disease, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a substantially non-elastic biomedical material which can be applied to an epicardial surface of the heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (b) applying said cardiac reinforcement device to said surface of the heart by applying said device to diametrically opposite sides of the heart and with opposite sides of the biomedical material overlying the opposite sides of the heart interconnected to one another; and (c) securing said cardiac reinforcement device to said surface of the heart with said opposing sides urged together by a spacing less than an unconstrained diastolic expansion of said diametrically opposite sides of the heart.
Claim 8
Independent Claim
133 words
A method for treating cardiac disease, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a substantially non-elastic biomedical material which can be applied to an epicardial surface of the heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (b) applying said cardiac reinforcement device to said surface of the heart by applying said device to diametrically opposite sides of the heart and with opposite sides of the biomedical material overlying the opposite sides of the heart interconnected to one another; and (c) securing said cardiac reinforcement device to said surface of the heart with said opposing sides urged together by a spacing less than an unconstrained diastolic expansion of said diametrically opposite sides of the heart.
Claim 9
Dependent Claim
34 words
The method according to claim 6 wherein said cardiac reinforcement device is a jacket with said predetermined size selected for said jacket to surround said surface of the heart and circumferentially constrain cardiac expansion.
Claim 10
Dependent Claim
26 words
The method according to claim 6 wherein said cardiac reinforcement device is applied to said surface of the heart under a parietal layer of the pericardium.
Claim 11
Dependent Claim
26 words
The method according to claim 6 wherein said cardiac reinforcement device is applied to said surface of the heart over a parietal layer of the pericardium.
Claim 12
Dependent Claim
25 words
The method according to claim 6 wherein said cardiac reinforcement device is applied to said surface of the heart using a minimally invasive surgical procedure.
Claim 13
Dependent Claim
13 words
The method according to claim 6 wherein said cardiac disease is heart failure.
Claim 14
Dependent Claim
12 words
The method according to claim 6 wherein said cardiac disease is cardiomyopathy.
Claim 15
Dependent Claim
13 words
The method according to claim 6 wherein said cardiac disease is valvular disease.
Claim 16
Dependent Claim
14 words
The method according to claim 6 wherein said cardiac disease is a cardiac arrhythmia.
Claim 17
Dependent Claim
19 words
The method according to claim 6 wherein said cardiac reinforcement device circumferentially surrounds the epicardial surface of the heart.
Claim 18
Dependent Claim
21 words
The method according to claim 6 wherein the cardiac reinforcement device provides cardiac constraint on diametrically opposing sides of the heart.
Claim 19
Dependent Claim
22 words
The method according to claim 6 wherein said cardiac reinforcement device includes diametrically opposed sides of biomedical material interconnected to one another.
Claim 20
Independent Claim
143 words
A method for reducing diastolic volume of a patient's heart, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a substantially non-elastic biomedical material which can be applied to an epicardial surface of said heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (ii) said biomedical material comprising a plurality of open cells, each open cell defined by multiple sides, each open cell sharing at least one of said multiple sides with an adjacent open cell; (b) applying said cardiac reinforcement device to said surface of said heart by applying said biomedical material to diametrically opposite sides of said heart and said opposite sides of said biomedical material are interconnected to one another; and (c) securing said cardiac reinforcement device to said epicardial surface of said heart.
Claim 21
Independent Claim
143 words
A method for reducing diastolic volume of a patient's heart, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a substantially non-elastic biomedical material which can be applied to an epicardial surface of said heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (ii) said biomedical material comprising a plurality of open cells, each open cell defined by multiple sides, each open cell sharing at least one of said multiple sides with an adjacent open cell; (b) applying said cardiac reinforcement device to said surface of said heart by applying said biomedical material to diametrically opposite sides of said heart and said opposite sides of said biomedical material are interconnected to one another; and (c) securing said cardiac reinforcement device to said epicardial surface of said heart.
Claim 22
Dependent Claim
25 words
The method according to claim 18 wherein the maximum predetermined size of the cardiac reinforcement device is less than an initial diastolic cardiac expansion volume.
Claim 23
Dependent Claim
19 words
The method according to claim 18 wherein said cardiac reinforcement device circumferentially surrounds the epicardial surface of the heart.
Claim 24
Independent Claim
142 words
A method for minimally invasive treatment of cardiac disease of a patient's heart, said method comprising: (a) making a first and second minimally invasive incision into said patient's thorax; (b) passing a thorascope into said first incision for intra-thoracic visualization; (c) passing a cannula into said second incision to a position for applying a cardiac reinforcement device to said patient's heart, wherein said cardiac reinforcement device comprises: (i) a biomedical material which can be applied to an epicardial surface of said heart and having a maximum predetermined size, said predetermined size selected to surround said surface of said heart and circumferentially constrain cardiac expansion beyond a predetermined limit; (d) applying said cardiac reinforcement device to said epicardial surface of said patient's heart; (e) removing said thorascope from said patient's thorax; (f) closing said first and said second incisions in said patient's thorax.
Claim 25
Independent Claim
142 words
A method for minimally invasive treatment of cardiac disease of a patient's heart, said method comprising: (a) making a first and second minimally invasive incision into said patient's thorax; (b) passing a thorascope into said first incision for intra-thoracic visualization; (c) passing a cannula into said second incision to a position for applying a cardiac reinforcement device to said patient's heart, wherein said cardiac reinforcement device comprises: (i) a biomedical material which can be applied to an epicardial surface of said heart and having a maximum predetermined size, said predetermined size selected to surround said surface of said heart and circumferentially constrain cardiac expansion beyond a predetermined limit; (d) applying said cardiac reinforcement device to said epicardial surface of said patient's heart; (e) removing said thorascope from said patient's thorax; (f) closing said first and said second incisions in said patient's thorax.
Claim 26
Dependent Claim
69 words
The method according to claim 21 wherein said cardiac reinforcement device comprises: (a) a jacket having a base end and an apical end, said base end having an opening for applying said jacket to said surface of said heart by passing said jacket over said surface of said heart such that when applied to said surface, said base of said jacket is oriented toward said base of said heart.
Claim 27
Dependent Claim
40 words
The method according to claim 21 wherein said cardiac reinforcement device further comprises a guidewire capable of passing around a circumference of said base end of said jacket to selectively expand said opening at said base end of said jacket.
Claim 28
Dependent Claim
50 words
The method according to claim 23 wherein said cardiac reinforcement device further comprises: (a) a guide tube, said guide tube capable of passing around a circumference of said base end of said jacket; (b) said guide wire being passed through said guide tube at said base end of said jacket.
Claim 29
Dependent Claim
101 words
The method according to claim 24 further comprising a step of: (a) passing through said cannula into said patient's thorax said jacket having said guide tube passed around said circumference of said base end of said jacket and said guide wire passed through said guide tube; (b) applying said jacket over said surface of said heart such that said base end of said jacket is oriented towards said base of said heart; (c) removing said guide wire from said guide tube; (d) removing said guide tube from said base end of said jacket; and (e) removing said cannula from said patient.
Claim 30
Dependent Claim
27 words
The method according to claim 25 further comprising a step of adjusting said predetermined size of said jacket after said jacket is applied to said patient's heart.
Claim 31
Dependent Claim
39 words
The method according to claim 21 wherein said biomedical material comprises a plurality of open cells, each open cell defined by multiple sides, each open cell sharing at least one of said multiple sides with an adjacent open cell.
Claim 32
Independent Claim
157 words
A method for treating cardiac disease, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a substantially non-elastic biomedical material which can be applied to an epicardial surface of said heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (ii) said substantially non-elastic biomedical material comprising a plurality of continuous strands of said biomedical material, said strands defining a plurality of open cells; (b) applying said cardiac reinforcement device to said surface of said heart by applying said device to diametrically opposite sides of said heart and with opposite sides of said biomedical material overlying said opposite sides of said heart interconnected to one another; and (c) securing said cardiac reinforcement device to said surface of said heart with said opposing sides urged together by a spacing less than an unconstrained diastolic expansion of said diametrically opposite sides of said heart.
Claim 33
Independent Claim
157 words
A method for treating cardiac disease, said method comprising: (a) selecting a cardiac reinforcement device, said cardiac reinforcement device comprising: (i) a substantially non-elastic biomedical material which can be applied to an epicardial surface of said heart and having a maximum predetermined size, said predetermined size selected to constrain cardiac expansion beyond a predetermined limit; (ii) said substantially non-elastic biomedical material comprising a plurality of continuous strands of said biomedical material, said strands defining a plurality of open cells; (b) applying said cardiac reinforcement device to said surface of said heart by applying said device to diametrically opposite sides of said heart and with opposite sides of said biomedical material overlying said opposite sides of said heart interconnected to one another; and (c) securing said cardiac reinforcement device to said surface of said heart with said opposing sides urged together by a spacing less than an unconstrained diastolic expansion of said diametrically opposite sides of said heart.
Claim 34
Dependent Claim
34 words
The method according to claim 28 wherein said cardiac reinforcement device is a jacket with said predetermined size selected for said jacket to surround said surface of said heart and circumferentially constrain cardiac expansion.
Claim 35
Dependent Claim
12 words
The method according to claim 28 wherein said cardiac disease is cardiomyopathy.
References Cited (Backward Citations)
US3983863A
Cited
US4048990A
Cited
US4428375A
Cited
US4403604A
Cited
JPS60203250A
Cited
US4630597A
Cited
US4690134A
Cited
US4957477A
Cited
US4878890A
Cited
US4936857A
Cited
US4821723A
Cited
EP0280564A2
Cited
JPH01145066A
Cited
US4976730A
Cited
US5186711A
Cited
US5057117A
Cited
US4973300A
Cited
US5087243A
Cited
US5131905A
Cited
US5429584A
Cited
US5150716A
Cited
US5290217A
Cited
US5524633A
Cited
US5192314A
Cited
US5383840A
Cited
US5256132A
Cited
US5356432A
Cited
US5356432B1
Cited
US5385156A
Cited
US5507779A
Cited
US5603337A
Cited
US5647380A
Cited
US5713954A
Cited
US5800528A
Cited
DE29517393U1
Cited
WO1998029041A1
Cited
WO1998058598A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-10-03 | 2004-04-03 | 2004-10-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-10-03 | 2008-04-03 | 2008-10-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-10-03 | 2012-04-03 | 2012-10-03 | $7700.00 | Window Closed / Lapsed |